The EC/ACP/WHO Partnership on Pharmaceutical Policies. Highlights of year 4
(2009; 8 pages)
(2009; 8 pages)
Access to good quality medicines can save lives, reduce suffering and significantly contribute to improving the health of populations, and to countries’ socio-economic development. Unfortunately, access to medicines in many developing countries, particularly in Africa, is still unacceptably low. Signed in March 2004, the EC/ACP/WHO Partnership on Pharmaceutical Policies is a 25 million euro programme that provides strategic and technical support to African, Caribbean and Pacific Island (ACP) countries and brings added value to WHO’s country-support work in the medicines area. The goal of the programme is to close the huge gap between the potential that essential medicines have to offer and the reality that for millions of people - particularly the poor and disadvantaged - medicines are unavailable, unaffordable, unsafe or improperly used. Support is provided to ACP countries to improve the performance of their pharmaceutical sector through: n Support for the development, monitoring and evaluation of national medicines policies (NMPs). n Strengthening all components of the pharmaceutical system. We constantly work for the improvement of the regulation, financing, procurement and governance of pharmaceuticals. Another priority is the strengthening of human resources for the pharmaceutical sector. n Promoting best practice, through specific support to countries, sub-regional groups and regions.